Clinical profile and management patterns in outpatients with heart failure in Spain: INCA study;Perfil clínico y patrones de manejo en los pacientes con insuficiencia cardíaca atendidos ambulatoriamente en España: estudio INCA (Estudio Insuficiencia Cardíaca)

Atencion Primaria

Volumn 41, Issue 7, 2009, Pages 394-401

  De Rivas Otero, Beatriz ^a   Permanyer Miralda, Gaieta ^b   Brotons Cuixart, Carlos ^c   Aznar Costa, Joaquin ^d   Sobreviela Blázquez, Eduardo ^e  

^a ASTRAZENECA   (United Kingdom)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c Unidad de Investigacion   (Spain)

^d Hospital Provincial de Nuestra Señora de Gracia   (Spain)

^e IQVIA   (United States)

Author keywords

Diabetes mellitus; Epidemiolog a; Epidemiology; Heart failure; Hipertensi n arterial sist mica; Hypertension; Insuficiencia card aca

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOLOGIST; CLINICAL ASSESSMENT; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; GROUPS BY AGE; HEALTH CENTER; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PHYSICIAN; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SPAIN;

EID: 69949146285     PISSN: 02126567     EISSN: 15781275     Source Type: Journal    
DOI: 10.1016/j.aprim.2008.10.022     Document Type: Article

References (15)

1. J.G.F. Cleland, A. KhDand, and A.L. Clark The heart failure epidemic: exactly how big is it? Eur Heart J 22 2001 623 626
2. F. Rodríguez-Artalejo, J.R. Banegas Banegas, and P. Guallar-Castillón Epidemiología de la insuficiencia cardíaca Rev Esp Cardiol 57 2004 163 170
3. J.G.F. Cleland, A. Cohen-Solal, J. Cosin Agular, R. Dietz, J. Eastaugh, and F. Follate Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey Lancet 360 2002 1631 1639
4. F. Otero-Raviña, L. Grigorian-Shamagian, Francis-Galiana, C. Názara-Otero, J.M. Fernández-Villaverde, and A. Del Álamo-Alonso Estudio gallego de insuficiencia cardiaca en atención primaria (estudio GALICAP) Rev Esp Cardiol 60 2007 373 383
5. F.H. Rutten, D.E. Grobbee, and A.W. Hoes Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice Eur J Heart Fail 5 2003 337 344
6. J.R. González Juanatey, E. Alegría Ezquerra, J.V. Lozano vidal, J.L. Llisterri Caro, and J.M. García Acuña González Maqueda I. Impacto de la hipertensión en las cardiopatías en España. Estudio Cardiotens 1999 Rev Esp Cardiol 54 2001 139 149
7. G.C. Rodríguez Roca, V. Barrios Alonso, J. Aznar Costa, J.L. Llisterrri Caro, F.J. Alonso Moreno, and C. Escobar Cervantes Características clínicas de los pacientes diagnosticados de insuficiencia cardíaca crónica asistidos en Atención Primaria Rev Clin Esp 207 2007 337 340
8. V. Barrios Alonso, G. Peña Pérez, J.R. González Juanatey, E. Alegría Ezquerra, J.V. Lozano Vidal, and J.L. Llisterri Caro Hipertensión arterial e insuficiencia cardiaca en las consultas de Atención Primaria y de Cardiología en España Rev Clin Esp 203 2003 334 342
9. M. Anguita Sánchez Características clínicas, tratamiento y morbimortalidad a corto plazo de pacientes con insuficiencia cardíaca controlados en consultas específicas de insuficiencia cardíaca. Resultados del registro BADAPIC Rev Esp Cardiol. 57 2004 1159 1169
10. M.F. Salvador, A. Sebaoun, F. Sonntag, P. Blanch, S. Silber, and J. Aznar Estudio europeo del tratamiento ambulatorio de la insuficiencia cardíaca realizado por cardiólogos Rev Esp Cardiol 57 2004 1170 1178
11. A. Maggioni, I. Anand, S.O. Gottlieb, R. Latini, G. Tognoni, J. Cohn, and on behalf of the Val-HeFT Investigators Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin converting enzyme inhibitors J Am Coll Cardiol 40 2002 1414 1421
12. J.J. McMurray, J. Ostergren, K. Swedberg, C.B. Granger, P. Held, and E.L. Michelson Effect of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial Lancet 362 2003 767 771 (Pubitemid 37093916)
13. M. Komajda, F. Follath, K. Swedberg, J. Cleland, J.C. Aguilar, and A. Cohne-Solal The euroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment Eur Heart J 24 2003 464 474 (Pubitemid 36286188)
14. P.A. Poole-Wilson, K. Swedberg, J.G.F. Cleland, A. DiLenarda, P. Hanrath, and M. Komadja Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): randomised controlled trial Lancet 362 2003 7 13
15. T.E. Owan, D.O. Hodge, R.M. Herges, S.J. Jacobsen, V.L. Roger, and M.M. Redfield Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med 355 2006 251 259